Nevro to Present at the Morgan Stanley Global Healthcare Conference on September 13, 2018
NEW YORK, Aug 30, 2018 /PRNewswire/ -- Nevro Corp (NASDAQ: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.
Nevro's management is scheduled to present on Thursday, September 13, 2018 at 3:30pm Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: www.nevro.com.
About Nevro Corp.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® System and Senza II™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
Investor Relations Contact:
Nevro Investor Relations
(415) 937-5402
ir@nevro.com
View original content with multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-the-morgan-stanley-global-healthcare-conference-300704139.html
SOURCE Nevro Corp.
Company Codes: NYSE:NVRO